Cargando…

The Immunotherapeutic Role of Type I and III Interferons in Melanoma and Non-Melanoma Skin Cancers

Interferons (IFNs) have demonstrated therapeutic potential in various skin cancers, specifically squamous cell carcinoma (SCC), basal cell carcinoma (BCC), and melanoma. The precise mechanism through which type I IFNs exert their antitumor effects in skin cancers is still being studied. However, int...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weir, Sydney A., KC, Kailash, Shoaib, Shoaib, Yusuf, Nabiha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303590/ https://www.ncbi.nlm.nih.gov/pubmed/37374093 http://dx.doi.org/10.3390/life13061310

Ejemplares similares

Type I Interferons: Key Players in Normal Skin and Select Cutaneous Malignancies
por: Ismail, Aimen, et al.
Publicado: (2014)

Role of Type I and II Interferons in Colorectal Cancer and Melanoma
por: Di Franco, Simone, et al.
Publicado: (2017)

Exploration of the Prognostic and Immunotherapeutic Value of B and T Lymphocyte Attenuator in Skin Cutaneous Melanoma
por: Dong, Xubin, et al.
Publicado: (2021)

Spectroscopic and Imaging Characteristics of Pigmented Non-Melanoma Skin Cancer and Melanoma in Patients with Skin Phototypes III and IV
por: Arroyo-Camarena, Stefanie, et al.
Publicado: (2016)

Novel Immunotherapeutic Approaches for Neuroblastoma and Malignant Melanoma
por: Morandi, Fabio, et al.
Publicado: (2018)

Modulation of Skin Cancer by the Stimulator of Interferon Genes
por: Oscherwitz, Max, et al.
Publicado: (2023)

2349 The role of interleukin-23 in human melanoma
por: Jani, Aditi, et al.
Publicado: (2018)

Dermoscopy of Melanoma and Non-melanoma Skin Cancers
por: Kato, Junji, et al.
Publicado: (2019)

A Review of Immunotherapeutic Strategies in Canine Malignant Melanoma
por: Almela, Ramón M., et al.
Publicado: (2019)

Identification of Lactate-Related Gene Signature for Prediction of Progression and Immunotherapeutic Response in Skin Cutaneous Melanoma
por: Xie, Yalin, et al.
Publicado: (2022)

A Novel Marine Natural Product Derived Pyrroloiminoquinone with Potent Activity against Skin Cancer Cells
por: Cowan, Jaden, et al.
Publicado: (2019)

Telomerase activity in melanoma and non-melanoma skin cancer
por: Parris, C N, et al.
Publicado: (1999)

Systemic Photoprotection in Melanoma and Non-Melanoma Skin Cancer
por: Hyeraci, Mariafrancesca, et al.
Publicado: (2023)

The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature
por: Zhou, Sitong, et al.
Publicado: (2021)

Mechanisms of action underlying the immunotherapeutic activity of Allovectin in advanced melanoma
por: Doukas, J, et al.
Publicado: (2012)

Influence of Genetic Variants in Type I Interferon Genes on Melanoma Survival and Therapy
por: Lenci, Romina Elizabeth, et al.
Publicado: (2012)

Roles of Type I and III Interferons in COVID-19
por: Choi, Hojun, et al.
Publicado: (2021)

Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer
por: Hochmann, Sarah, et al.
Publicado: (2018)

Ex Vivo Derived Primary Melanoma Cells: Implications for Immunotherapeutic Vaccines
por: Suriano, Robert, et al.
Publicado: (2013)

Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
por: Wolchok, Jedd D, et al.
Publicado: (2013)

Healthcare Costs of Metastatic Cutaneous Melanoma in the Era of Immunotherapeutic and Targeted Drugs
por: Leeneman, Brenda, et al.
Publicado: (2020)

Beyond Ipilimumab: a review of immunotherapeutic approaches in clinical trials in melanoma
por: Middleton, Gary
Publicado: (2020)

Peptide Vaccines in Melanoma: Chemical Approaches towards Improved Immunotherapeutic Efficacy
por: Biri-Kovács, Beáta, et al.
Publicado: (2023)

Adjuvant interferon in the treatment of melanoma
por: Middleton, M R
Publicado: (1999)

Adjuvant interferon in the treatment of melanoma
por: Kirkwood, J M
Publicado: (2000)

Type I and type III interferon in opposition?
por: Park, Matthew D.
Publicado: (2020)

Silibinin and non-melanoma skin cancers
por: Prasad, Ram Raj, et al.
Publicado: (2020)

Immunotherapy for Non-melanoma Skin Cancer
por: Shalhout, Sophia Z., et al.
Publicado: (2021)

Editorial: The Evolving Role of Immunotherapy in Non-Melanoma Skin Cancers
por: Guida, Michele, et al.
Publicado: (2022)

The Role of Radiation Therapy in the Treatment of Non-Melanoma Skin Cancer
por: Yosefof, Eyal, et al.
Publicado: (2023)

Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation study
por: Gutzmer, R, et al.
Publicado: (2016)

Prospective Epigenetic Actions of Organo-Sulfur Compounds against Cancer: Perspectives and Molecular Mechanisms
por: Shoaib, Shoaib, et al.
Publicado: (2023)

Phenethyl Isothiocyanate Induces Apoptosis Through ROS Generation and Caspase-3 Activation in Cervical Cancer Cells
por: Shoaib, Shoaib, et al.
Publicado: (2021)

Immunotherapeutic targeting of HSP90 client proteins in BRAF-inhibitor resistant melanoma
por: Fecek, Ronald J, et al.
Publicado: (2015)

Trends in survival and costs in metastatic melanoma in the era of novel targeted and immunotherapeutic drugs
por: Franken, M.G., et al.
Publicado: (2021)

Harnessing the immunotherapeutic potential of CDK4/6 inhibitors in melanoma: is timing everything?
por: Lelliott, Emily J., et al.
Publicado: (2022)

Stromal Factors as a Target for Immunotherapy in Melanoma and Non-Melanoma Skin Cancers
por: Fujimura, Taku
Publicado: (2022)

Classic and new strategies for the treatment of advanced melanoma and non-melanoma skin cancer
por: Rubatto, Marco, et al.
Publicado: (2023)

Primary Retroperitoneal Melanoma Presented in a Rare Extracutaneous Site for Malignant Melanoma
por: Alsharedi, Mohamed, et al.
Publicado: (2016)

The role of interferons type I, II and III in myositis: A review
por: Bolko, Loïs, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b9a3eqk6ecpf4gabmqpl066uq5